Literature DB >> 15708975

T cells from epicutaneously immunized mice are prone to T cell receptor revision.

Margaret S Bynoe1, Christophe Viret, Richard A Flavell, Charles A Janeway.   

Abstract

Epicutaneous immunization of T cell receptor (TCR) transgenic (Tg) mice whose CD4(+) T cells are specific for the Ac1-11 fragment of myelin basic protein (MBP) with Ac1-11 elicits T cells with dominant suppressor/regulatory activity that confers protection against Ac1-11-induced experimental autoimmune encephalomyelitis. We now report that such disease-resistant MBP TCR Tg mice also harbor a sizeable fraction of peripheral CD4(+) T cells lacking surface expression of the Tg TCR beta chain and expressing diverse, endogenously rearranged TCR beta chains. Ex vivo incubation at physiological temperature caused the loss of neo-beta-chain expression and reversion to the MBP alphabeta TCR(+) phenotype. The presence of recombination activating gene 1 and 2 proteins in CD4(+) T cells with revised TCRs was consistent with effective V(D)J recombination activity. The emergence of these cells did not depend on the thymic compartment. We conclude that in mice epicutaneously immunized with an autoantigen, peripheral specific T cells are susceptible to multiple mechanisms of tolerance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708975      PMCID: PMC549496          DOI: 10.1073/pnas.0409880102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Assessment of animal models for MS and demyelinating disease in the design of rational therapy.

Authors:  L Steinman
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Cutting edge: recombinase-activating gene expression and V(D)J recombination in CD4+CD3low mature T lymphocytes.

Authors:  E Lantelme; B Palermo; L Granziero; S Mantovani; R Campanelli; V Monafo; A Lanzavecchia; C Giachino
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

Review 3.  The RAG proteins and V(D)J recombination: complexes, ends, and transposition.

Authors:  S D Fugmann; A I Lee; P E Shockett; I J Villey; D G Schatz
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 5.  Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe.

Authors:  P J Fink; C J McMahan
Journal:  Immunol Today       Date:  2000-11

Review 6.  T cell receptor editing.

Authors:  M A McGargill; K A Hogquist
Journal:  Immunol Lett       Date:  2000-12-01       Impact factor: 3.685

7.  Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity.

Authors:  L F Wang; C C Sun; J T Wu; R H Lin
Journal:  Clin Exp Allergy       Date:  1999-02       Impact factor: 5.018

8.  Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis.

Authors:  D Olivares-Villagómez; A K Wensky; Y Wang; J J Lafaille
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

9.  Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4.

Authors:  C A Herrick; H MacLeod; E Glusac; R E Tigelaar; K Bottomly
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

10.  Receptor revision in peripheral T cells creates a diverse V beta repertoire.

Authors:  C J McMahan; P J Fink
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

View more
  9 in total

1.  TCR revision generates functional CD4+ T cells.

Authors:  J Scott Hale; Maramawit Wubeshet; Pamela J Fink
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 2.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

3.  Modulation of TCRβ surface expression during TCR revision.

Authors:  Kalynn B Simmons; Maramawit Wubeshet; Kristina T Ames; Catherine J McMahan; J Scott Hale; Pamela J Fink
Journal:  Cell Immunol       Date:  2011-11-15       Impact factor: 4.868

Review 4.  T-cell receptor revision: friend or foe?

Authors:  J Scott Hale; Pamela J Fink
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

5.  Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.

Authors:  William V Nikolic; Yun Bai; Demian Obregon; Huayan Hou; Takashi Mori; Jin Zeng; Jared Ehrhart; R Douglas Shytle; Brian Giunta; Dave Morgan; Terrence Town; Jun Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

Review 6.  The dynamic lives of T cells: new approaches and themes.

Authors:  Yvonne J Yamanaka; Todd M Gierahn; J Christopher Love
Journal:  Trends Immunol       Date:  2012-11-28       Impact factor: 16.687

7.  Receptor revision in CD4 T cells is influenced by follicular helper T cell formation and germinal-center interactions.

Authors:  Lauren E Higdon; Katherine A Deets; Travis J Friesen; Kai-Yin Sze; Pamela J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

8.  Cutting edge: TCR revision affects predominantly Foxp3 cells and skews them toward the Th17 lineage.

Authors:  Dietmar Zehn; Michael J Bevan; Pamela J Fink
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

9.  Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.

Authors:  Chen Chen; Courtney Dow; Peng Wang; John Sidney; Amanda Read; Allen Harmsen; James E Samuel; Bjoern Peters
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.